999 related articles for article (PubMed ID: 16085017)
1. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
2. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
3. Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss.
Geula C; Bu J; Nagykery N; Scinto LF; Chan J; Joseph J; Parker R; Wu CK
J Comp Neurol; 2003 Jan; 455(2):249-59. PubMed ID: 12454989
[TBL] [Abstract][Full Text] [Related]
4. Calbindin-D28k immunoreactivity within the cholinergic and GABAergic projection neurons of the basal forebrain.
Smith ML; Hale BD; Booze RM
Exp Neurol; 1994 Dec; 130(2):230-6. PubMed ID: 7867752
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
[TBL] [Abstract][Full Text] [Related]
6. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
Rasool CG; Svendsen CN; Selkoe DJ
Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
[TBL] [Abstract][Full Text] [Related]
7. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
Mufson EJ; Jaffar S; Levey AI
J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
[TBL] [Abstract][Full Text] [Related]
8. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
[TBL] [Abstract][Full Text] [Related]
9. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
10. Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease.
Härtig W; Stieler J; Boerema AS; Wolf J; Schmidt U; Weissfuss J; Bullmann T; Strijkstra AM; Arendt T
Eur J Neurosci; 2007 Jan; 25(1):69-80. PubMed ID: 17241268
[TBL] [Abstract][Full Text] [Related]
11. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
[TBL] [Abstract][Full Text] [Related]
12. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease.
Ishunina TA; van Beurden D; van der Meulen G; Unmehopa UA; Hol EM; Huitinga I; Swaab DF
Neurobiol Aging; 2005 Feb; 26(2):173-94. PubMed ID: 15582747
[TBL] [Abstract][Full Text] [Related]
13. Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons.
Ding X; MacTavish D; Kar S; Jhamandas JH
Neurobiol Dis; 2006 Feb; 21(2):413-20. PubMed ID: 16246567
[TBL] [Abstract][Full Text] [Related]
14. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch EC
Exp Neurol; 1997 May; 145(1):245-52. PubMed ID: 9184126
[TBL] [Abstract][Full Text] [Related]
15. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
[TBL] [Abstract][Full Text] [Related]
16. Rabbit forebrain cholinergic system: morphological characterization of nuclei and distribution of cholinergic terminals in the cerebral cortex and hippocampus.
Varga C; Härtig W; Grosche J; Keijser J; Luiten PG; Seeger J; Brauer K; Harkany T
J Comp Neurol; 2003 Jun; 460(4):597-611. PubMed ID: 12717717
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in the rat basal forebrain during development and following lesions of connections.
Sophou S; Dori I; Antonopoulos J; Parnavelas JG; Dinopoulos A
Eur J Neurosci; 2006 Jul; 24(2):573-85. PubMed ID: 16903859
[TBL] [Abstract][Full Text] [Related]
18. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis-related factors (Fas receptor, Fas ligand, FADD) in early tooth development of the field vole (Microtus agrestis).
Matalova E; Tucker AS; Misek I
Arch Oral Biol; 2005 Feb; 50(2):165-9. PubMed ID: 15721145
[TBL] [Abstract][Full Text] [Related]
20. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice.
Mufson EJ; Counts SE; Perez SE; Binder L
Neuropeptides; 2005 Jun; 39(3):233-7. PubMed ID: 15893372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
